Citation: | PENG Yifan, WANG Zengming, WANG Rongrong, DU Yimeng, GAO Xiang, ZHENG Aiping, ZHANG Hui. Preparation and in vitro and in vivo evaluation of oral curcumin nanocrystalline capsules[J]. Journal of China Pharmaceutical University, 2021, 52(2): 211-218. DOI: 10.11665/j.issn.1000-5048.20210210 |
[1] |
.Clin Cancer Res,2008,14(14):4491-4499.
|
[2] |
Wo XD,Hong XQ,Gao CX,et al.Long-period virulent test of curcumin[J].J Zhejiang Tradit Chin Med Coll (浙江中医学院学报),2000,24(1):61-65.
|
[3] |
Wo XD,Hong XQ,Gao CX.Maximum toleration test of curcumin[J].J Zhejiang Tradit Chin Med Coll (浙江中医学院学报),2000,24(2):55-55.
|
[4] |
Sharma RA,McLelland HR,Hill KA,et al.Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer[J].Clin Cancer Res,2001,7(7):1894-1900.
|
[5] |
Lao CD,Ruffin MT,Normolle D,et al.Dose escalation of a curcuminoid formulation[J].BMC Complement Altern Med,2006,6:10.
|
[6] |
Cheng AL,Hsu CH,Lin JK,et al.Phase I clinical trial of curcumin,a chemopreventive agent,in patients with high-risk or pre-malignant lesions[J].Anticancer Res,2001,21(4b):2895-2900.
|
[7] |
T?nnesen HH,Másson M,Loftsson T.Studies of curcumin and curcuminoids.XXVII.Cyclodextrin complexation:solubility,chemical and photochemical stability[J].Int J Pharm,2002,244(1/2):127-135.
|
[8] |
Khan MA.Enhancement of solubility of poorly water soluble drugs diclofenac Sodium by mixed solvency approach[J].Res J Pharm Dosage Form Technol,2013,5(1):39-41.
|
[9] |
Millard J,Alvarez-Nú?ez F,Yalkowsky S.Solubilization by cosolvents.Establishing useful constants for the log-linear model[J].Int J Pharm,2002,245(1/2):153-166.
|
[10] |
Gupta NK,Dixit VK.Bioavailability enhancement of curcumin by complexation with phosphatidyl choline[J].J Pharm Sci,2011,100(5):1987-1995.
|
[11] |
Shulman M,Cohen M,Soto-Gutierrez A,et al.Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin.[corrected][J].PLoS One,2011,6(4):
|
[12] |
Ko?bia? M,Gierycz P.Comparison of aqueous and 1-octanol solubility as well as liquid-liquid distribution of acyclovir derivatives and their complexes with hydroxypropyl-β-cyclodextrin[J].J Solution Chem,2013,42(4):866-881.
|
[13] |
Serajuddin AT.Salt formation to improve drug solubility[J].Adv Drug Deliv Rev,2007,59(7):603-616.
|
[14] |
Liversidge GG,Cundy KC.Particle size reduction for improvement of oral bioavailability of hydrophobic drugs:I.Absolute oral bioavailability of nanocrystalline danazol in beagle dogs[J].Int J Pharm,1995,125(1):91-97.
|
[15] |
Rao S,Song Y,Peddie F,et al.Particle size reduction to the nanometer range:a promising approach to improve buccal absorption of poorly water-soluble drugs[J].Int J Nanomedicine,2011,6:1245-1251.
|
[16] |
Sigfridsson K,Lundqvist AJ,Strimfors M.Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development[J].Drug Dev Ind Pharm,2009,35(12):1479-1486.
|
[17] |
Liversidge GG,Conzentino P.Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats[J].Int J Pharm,1995,125(2):309-313.
|
[18] |
Zhou XY,Lin HQ,Lei W.Research progress of insoluble drug nanocrystals[J].Cent South Pharm (中南药学),2013,11(5):353-358.
|
[19] |
Yue PF,Liu Y,Xie J,et al.Review and prospect on preparation technology of drug nanocrystals in the past thirty years[J].Acta Pharm Sin (药学学报),2018,53(4):529-537.
|
[20] |
Peltonen L,Hirvonen J.Pharmaceutical nanocrystals by nanomilling:critical process parameters,particle fracturing and stabilization methods[J].J Pharm Pharmacol,2010,62(11):1569-1579.
|
[21] |
Chang TL,Zhan HL,Liang DN,et al.Nanocrystal technology for drug formulation and delivery[J].Front Chem Sci Eng,2015,9(1):1-14.
|
[22] |
Yu WB,Jin ZM,Jian YF,et al.The pharmacokinetics of curcumin extract and turmeric monomer after administration in rats[J].Pharmacol Clin Chin Mater Med (中药药理与临床),2018,34(5):30-33.
|
[1] | ZHONG Shuisheng, LUO Zhu, SUN Luning, JANVIER Engelbert Agbokponto, LIANG Maozhi, DING Li. Pharmacokinetic interaction between bencycloquidium bromide nasal spray and budesonide nasal spray in healthy volunteers[J]. Journal of China Pharmaceutical University, 2013, 44(5): 447-450. DOI: 10.11665/j.issn.1000-5048.20130512 |
[2] | YANG Zhi-xin, WANG Jing, CHEN Zhong-xin, WANG Rui, XIE Li, CHANG Shuang. Comparative study of three pore-forming agents for colon coating solution of 5-aminosalicylic acid[J]. Journal of China Pharmaceutical University, 2012, 43(4): 325-328. |
[3] | SONG Yi-ting, ZHOU Hong, SUN Wan-jin, GAO Yuan, LI Chao. Preparation and physicochemical characterization of a spray-dried lornoxicam self-microemulsifying system[J]. Journal of China Pharmaceutical University, 2012, 43(2): 137-141. |
[4] | ZHAO Yan-rong, DING Li, RAO Ya-kun, TANG Xiao-wen, DING Jun-hong. Stability and degradation products of otilonium bromide in different media[J]. Journal of China Pharmaceutical University, 2010, 41(6): 548-554. |
[5] | CHEN Liang, TONG Xin-yong, SHI Yuan, TAN Yan. Preparation of fluticasone propionate nasal spray and its spray characteristics[J]. Journal of China Pharmaceutical University, 2010, 41(6): 524-528. |
[6] | YANG Yan, ZHU Jia-bi, ZHENG Chun-li, CHEN Sheng-jun. Preparation and characterization of aqueous polymer dispersions with high flexibility for coating[J]. Journal of China Pharmaceutical University, 2009, 40(4): 310-315. |
[7] | Preparation of Compound Lonicera japonica Effervescent Spray[J]. Journal of China Pharmaceutical University, 2002, (4): 39-41. |
[8] | Study onDrug Release Characteristics from Aqueous Ethylcellulose Dispersion Coated Pellets[J]. Journal of China Pharmaceutical University, 2000, (1): 27-30. |
[9] | Preparation and Evaluation of Enteric Tablet Erythromycin Coated by Acrylic Resin No.2 Pseudolatex[J]. Journal of China Pharmaceutical University, 1994, (5): 267-270. |
[10] | Studies on Aqueous Coating Technique for Acetylsalicylic Acid Enteric Tablets[J]. Journal of China Pharmaceutical University, 1991, (3): 154-157. |